Cargando...
Sofosbuvir/velpatasvir: A promising combination
Hepatitis C virus (HCV) affects 3% of the world population. It represents the main cause of chronic liver disease and is responsible for extra-hepatic complications, such as type 2 diabetes and cardiovascular diseases. HCV includes 7 genotypes differing in the nucleotide sequence variability, the ge...
Gardado en:
| Publicado en: | World J Hepatol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4937166/ https://ncbi.nlm.nih.gov/pubmed/27429714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v8.i19.785 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|